Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Psychopharmacology|April 17, 2004
Sensorimotor gating in mice is disrupted after AM404, an anandamide reuptake and degradation inhibitorEmilio Fernandez-Espejo, Beatriz Galan-Rodriguez
Frontiers in Neuroscience|March 29, 2011
Elk-1 a transcription factor with multiple facets in the brainAntoine Besnard, Beatriz Galan-Rodriguez, Peter Vanhoutte, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 18, 2005
Role for dopamine neurons of the rostral linear nucleus and periaqueductal gray in the rewarding and sensitizing properties of heroinJuan A Flores, Beatriz Galan-Rodriguez, Susana Ramiro-Fuentes, et al.
The European Journal of Neuroscience|October 8, 2016
Coupling of D2R Short but not D2R Long receptor isoform to the Rho/ROCK signaling pathway renders striatal neurons vulnerable to mutant huntingtinBeatriz Galan-Rodriguez, Elodie Martin, Emmanuel Brouillet, et al.
Neurobiology of Disease|June 15, 2004
Effects on turning of microinjections into basal ganglia of D(1) and D(2) dopamine receptors agonists and the cannabinoid CB(1) antagonist SR141716A in a rat Parkinson's modelFadwa El-Banoua, Isabel Caraballo, Juan A Flores, et al.
Brain Research. Brain Research Reviews|August 23, 2005
Cells of the sympathoadrenal lineage: biological properties as donor tissue for cell-replacement therapies for Parkinson's diseaseEmilio Fernandez-Espejo, Jose A Armengol, Juan A Flores, et al.
Plos One|December 18, 2009
Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-induced mouse striatal neuron dysfunctions via Rho/ROCK-II activationCarole Deyts, Beatriz Galan-Rodriguez, Elodie Martin, et al.
Neurobiology of Disease|March 10, 2005
Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonismEmilio Fernandez-Espejo, Isabel Caraballo, Fernando Rodriguez de Fonseca, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 11, 2004
Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid functionEmilio Fernandez-Espejo, Isabel Caraballo, Fernando Rodriguez de Fonseca, et al.
Pageof 1